Mave Vidya, Chandanwale Ajay, Kagal Anju, Khadse Sandhya, Kadam Dileep, Bharadwaj Renu, Dohe Vaishali, Robinson Matthew L, Kinikar Aarti, Joshi Samir, Raichur Priyanka, McIntire Katie, Kanade Savita, Sachs Jonathan, Valvi Chhaya, Balasubramanian Usha, Kulkarni Vandana, Milstone Aaron M, Marbaniang Ivan, Zenilman Jonathan, Gupta Amita
Johns Hopkins University School of Medicine, Baltimore, Maryland.
Byramjee Jeejeebhoy Government Medical College, Pune, India.
J Infect Dis. 2017 Apr 15;215(8):1312-1320. doi: 10.1093/infdis/jix114.
In India, antimicrobial consumption is high, yet systematically collected data on the epidemiology, risk factors, and outcomes of antimicrobial-resistant infections are limited.
A prospective study of adults and children hospitalized for acute febrile illness was conducted between August 2013 and December 2015. In-hospital outcomes were recorded, and logistic regression was performed to identify independent predictors of community-onset antimicrobial-resistant infections.
Among 1524 patients hospitalized with acute febrile illness, 133 isolates were found among 115 patients with community-onset infections; 66 isolates (50.0%) were multidrug resistant and, of 33 isolates tested for carbapenem susceptibility, 12 (36%) were resistant. Multidrug-resistant infections were associated with recent antecedent antibiotic use (adjusted odds ratio [aOR], 4.17; 95% confidence interval [CI], 1.19-19.7) and were independently associated with mortality (aOR, 6.06; 95% CI, 1.2-55.7).
We found a high burden of community-onset antimicrobial-resistant infection among patients with acute febrile illness in India. Multidrug-resistant infection was associated with prior antibiotic use and an increased risk of mortality.
在印度,抗菌药物的消耗量很高,但关于抗菌药物耐药性感染的流行病学、危险因素和结局的系统收集数据有限。
在2013年8月至2015年12月期间,对因急性发热性疾病住院的成人和儿童进行了一项前瞻性研究。记录住院结局,并进行逻辑回归分析以确定社区获得性抗菌药物耐药性感染的独立预测因素。
在1524例因急性发热性疾病住院的患者中,115例社区获得性感染患者中发现了133株分离菌;66株(50.0%)为多重耐药菌,在33株进行碳青霉烯敏感性检测的分离菌中,12株(36%)耐药。多重耐药性感染与近期使用过抗生素有关(校正比值比[aOR],4.17;95%置信区间[CI],1.19-19.7),且与死亡率独立相关(aOR,6.06;95%CI,1.2-55.7)。
我们发现印度急性发热性疾病患者中社区获得性抗菌药物耐药性感染负担很高。多重耐药性感染与先前使用抗生素有关,且死亡风险增加。